If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to
A) Design a compound that mimics epinephrine and can bind to the epinephrine receptor.
B) Design a compound that stimulates cAMP production in liver cells.
C) Design a compound to stimulate G protein activity in liver cells.
D) Design a compound that increases phosphodiesterase activity.
E) All of the above are possible approaches.